Through implementing new technologies for tissue and cell building, regenerative medicine is expanding and revolutionising the healthcare sector

 

Regenerative medicine is a rapidly expanding field in regions such as Japan, the U.S, and the U.K and finds application in tissue regeneration technology. It is used in treating different forms of pain and trauma. The potential uses of these procedures and technologies are practically endless. For example, doctors have treated Crohn's Disease by transplanting stem cells from a healthy donor, which has increased the success rates in helping the patient to deal with the effects of Crohn's.

Regenerative medicine uses a multitude of tools and technologies such as cell-based therapeutics, tissue engineering, gene therapy, and pharmacogenetics. Cell-based therapeutics are used to assist in tissue repair after trauma or disease. Gene therapy treatments are currently being tested for the treatment of Parkinson's disease, and multiple sclerosis.

Many nations around the world have been investing in the R&D of regenerative medicine. For instance, in recent times, Japan is experiencing an increase in demand for 3D tissue bioprinters, which can be used for the production of effective regenerative medicine. These printers allow researchers and medical professionals to re-create blood vessels, skin, cartilage, and other complex tissues.

In addition to stem cell therapy, other areas of regenerative medicine are also expanding such as micro implant technology. Micro implants are used to treat burns and tissue damage. As medical professionals become more aware of the benefits of using micro-implants, they are also looking at how these treatments can be applied to physical injury.

There are several applications of regenerative medicine in the fields of medical science. Some of the most exciting possibilities involve using stem cells from an individual's body to help create healthy cells in another person's body. For instance, in March 2020, RenovaCare, Inc., a developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, announced that its SkinGun is being used to apply regenerative cells in a preclinical study of new gene therapies, underway at King’s College London.